文献速递慢性肾脏病血液净化与透析遗传性与小管间质肾病

晚期肾脏病骨质疏松的诊断与管理:综述

Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review.
PubMed 文献 · Am J Kidney Dis · 2021-08-20

该综述讨论晚期慢性肾脏病(CKD)及维持性透析患者骨质疏松和骨折的诊断、管理与监测。双能X线吸收法(DXA)等影像学有助于识别骨折高风险者,骨活检仍是判断骨转换的金标准;骨质疏松药物或可预防骨折,但该人群数据有限,需结合影像、生物标志物和骨活检指导治疗。

要点

  • DXA有助识别晚期CKD骨折高风险患者。
  • 骨活检是判断骨转换状态的金标准。
  • 骨质疏松药物或可预防骨折,但晚期CKD数据有限。

核心结论

  • 晚期CKD和透析患者骨质疏松与骨折常见,影像学、生物标志物和骨活检可指导靶向骨转换异常的治疗。

研究设计与样本

  • 综述,检索并讨论晚期CKD或维持性透析患者骨质疏松和骨折诊断、管理与监测的最新文献。

主要发现

  • 双能X线吸收法(DXA)等影像学有助于识别骨折风险最高的CKD患者。
  • 甲状旁腺激素和骨特异性碱性磷酸酶浓度可辅助评估骨转换状态。
  • 骨活检仍是确定晚期肾病合并骨质疏松患者骨转换的金标准。
  • 骨质疏松药物数据在晚期CKD患者中有限。

临床怎么用

  • 临床可结合影像学、生物标志物和骨活检,使用新型药物靶向动力性骨病和高骨转换病等异常。

局限性

  • 骨质疏松药物在晚期CKD患者中的数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Osteoporosis and fractures are common in persons with advanced chronic kidney disease (CKD) and on maintenance dialysis. Although the diagnosis of osteoporosis in this population can be difficult, imaging, especially with dual-energy x-ray absorptiometry (DXA), is helpful in identifying persons with CKD at the highest risk of fracture. Although blood biomarkers including parathyroid hormone and bone-specific alkaline phosphatase concentrations can aid in assessing bone turnover state, bone biopsy remains the gold standard in determining bone turnover in persons with advanced kidney disease and osteoporosis. With the increasing armamentarium of osteoporosis drugs, it now may be possible to prevent many fractures in advanced CKD. Unfortunately, data on these drugs are limited in persons with advanced CKD. Clinicians, aided by advances in imaging, biomarkers, and bone biopsy can now use these novel agents to target bone turnover abnormalities such as adynamic bone disease and high bone turnover disease. This review will discuss the most recent literature surrounding the diagnosis, management, and monitoring of osteoporosis and fractures in persons with advanced CKD or on maintenance dialysis.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Ginsberg C, Ix JH. Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review. Am J Kidney Dis. 2021. PMID: 34419519. doi:10.1053/j.ajkd.2021.06.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。